Specify a stock or a cryptocurrency in the search bar to get a summary
Genprex Inc
GNPXGenprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas. Address: 3300 Bee Cave Road, Austin, TX, United States, 78746
Analytics
WallStreet Target Price
8 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures GNPX
Dividend Analytics GNPX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GNPX
Stock Valuation GNPX
Financials GNPX
Results | 2019 | Dynamics |